- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Inactive Lifestyle Males in Germany
Total 647 results
-
Achieve Life SciencesTeva Branded Pharmaceutical Products R&D, Inc.CompletedProstate CancerUnited States, Belgium, Canada, France, Germany, Hungary, Israel, Italy, Korea, Republic of, Netherlands, Spain, United Kingdom
-
Cell GenesysTerminatedProstate CancerUnited States, France, Belgium, Canada, United Kingdom, Sweden, Netherlands, Germany
-
Heidelberg UniversityRecruitingHealthy | Kidney Failure, Chronic | Transplantation | Peritoneal Dialysis ComplicationUnited States, Austria, Belgium, Czechia, France, Germany, Hungary, Italy, Lithuania, Malaysia, Poland, Spain, Sweden, Switzerland, Turkey
-
PfizerTerminatedProstatic NeoplasmsUnited States, Canada, Spain, Belgium, Finland, Italy, Korea, Republic of, Poland, Portugal, Slovakia, Sweden, Denmark, Taiwan, China, Australia, Germany, Israel, United Kingdom, Brazil, France, Czech Republic, Peru
-
Bristol-Myers SquibbCompletedProstatic NeoplasmsUnited States, Argentina, Czech Republic, India, Italy, Korea, Republic of, Mexico, Poland, Spain, Sweden, Germany, Australia, Canada, Peru, Russian Federation, Hungary, Ireland, South Africa, France, Brazil, Romania, United Kingdom, Finla... and more
-
Cell GenesysTerminatedProstate CancerUnited States, France, United Kingdom, Italy, Germany, Netherlands, Canada, Poland, Sweden, Belgium
-
Janssen Research & Development, LLCCompletedProstate CancerUnited States, Australia, France, United Kingdom, Belgium, Germany, Spain, Canada, Netherlands, Greece, Sweden
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Merck Healthcare Germany GmbH, an affiliate of Merck KGaA, Darmstadt, GermanyActive, not recruitingCarcinoma, Renal CellGermany, Greece, Belgium, Russian Federation
-
Novartis PharmaceuticalsRecruitingAcute Kidney Injury Following Cardiac SurgeryFrance, Taiwan, Belgium, Germany, Argentina, Spain, Czechia, Hungary, Singapore, Estonia, Brazil, Lithuania
-
AbbottCompletedProstatic NeoplasmsCanada, United States, Spain, Belgium, Australia, Italy, United Kingdom, Germany, France, Sweden, South Africa, Netherlands, Ireland, New Zealand, Greece, Poland, Austria
-
SanofiCompletedProstate CancerKorea, Republic of, Spain, United States, Argentina, Peru, Romania, Taiwan, United Kingdom, Belgium, Chile, Netherlands, Australia, Germany, Tunisia, Brazil, Canada, France, Hungary, Poland, Russian Federation, South Africa, Turkey
-
Alnylam PharmaceuticalsRecruitingPrimary Hyperoxaluria Type 1France, Spain, United States, Israel, Belgium, Switzerland, Germany, United Kingdom, Italy, Canada
-
Ferring PharmaceuticalsMemorial Sloan Kettering Cancer Center; Duke Clinical Research InstituteTerminatedProstate CancerUnited States, France, Canada, Czechia, Finland, Germany, Greece, Poland, Russian Federation, Slovakia, South Africa, United Kingdom
-
Bristol-Myers SquibbCompletedProstate CancerUnited States, France, Mexico, Sweden, Canada, Australia, Italy, Colombia, Denmark, Argentina, Chile, Spain, Germany, Puerto Rico, United Kingdom, Czech Republic, Romania, Norway, Poland, Netherlands, Brazil, Hungary, Turkey, Greece
-
Myovant Sciences GmbHCompletedA Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer (HERO)Prostate CancerUnited States, Germany, Spain, New Zealand, Brazil, Belgium, Australia, Austria, Canada, China, Denmark, Finland, France, Italy, Japan, Korea, Republic of, Netherlands, Poland, Slovakia, Sweden, Taiwan, United Kingdom
-
NovaceaTerminatedProstate CancerUnited States, Canada, Germany, Romania, Czech Republic, Former Serbia and Montenegro, Hungary, Puerto Rico, Slovakia
-
SanofiCompletedProstate CancerAustralia, Portugal, Spain, Peru, Sweden, Romania, Russian Federation, Belarus, Israel, France, Italy, Denmark, Turkey, Germany, United States, Brazil, Canada, China, Czechia, Finland, Japan, Mexico, Poland, Taiwan, Ukraine
-
Bristol-Myers SquibbCompletedProstate CancerUnited States, Argentina, Italy, Mexico, Spain, United Kingdom, Netherlands, Australia, Colombia, Belgium, Austria, Denmark, Puerto Rico, France, Israel, Peru, Romania, Russian Federation, Hungary, Brazil, Germany, Czech Republic, C... and more
-
IpsenActive, not recruitingLocally Advanced or Metastatic Renal Cell CarcinomaSpain, France, United Kingdom, Switzerland, Germany, Netherlands, Austria
-
CelgeneCompletedProstate CancerUnited States, Spain, France, Belgium, Australia, Denmark, Austria, United Kingdom, Netherlands, Poland, Israel, Italy, Germany, Greece, Canada, Czechia, Hungary, Mexico, Russian Federation, South Africa, Sweden
-
Hoffmann-La RocheCompletedProstatic Neoplasms, Castration-ResistantUnited States, Korea, Republic of, Belgium, United Kingdom, Canada, China, Denmark, France, Greece, Poland, Spain, Italy, Czechia, Japan, Switzerland, Australia, Germany, Austria, Hungary, Russian Federation, Taiwan
-
AstraZenecaCompletedProstate CancerSweden, United States, Brazil, France, Peru, Spain, United Kingdom, Germany, Poland, Romania, Finland, Canada, Argentina, Australia, South Africa, Czech Republic, India, Netherlands, Italy, Switzerland, Korea, Republic of, Hungary, ... and more
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerSpain, Taiwan, France, Algeria, Argentina, Australia, Austria, Brazil, Canada, Colombia, Egypt, Germany, Indonesia, Israel, Italy, Korea, Republic of, Lebanon, Mexico, Netherlands, New Zealand, Oman, Peru, Philippines, Saudi Arabia, Sin... and more
-
Novartis PharmaceuticalsRecruitingCarcinoma, Renal Cell | Carcinoma, Non-Small-Cell Lung | Squamous Cell Carcinoma of Head and Neck | Esophageal Squamous Cell CarcinomaJapan, France, Italy, Spain, Belgium, Germany, Taiwan, United States, Singapore
-
Janssen Research & Development, LLCCompletedProstate NeoplasmsCanada, France, Poland, Ukraine, United Kingdom, China, Belgium, Spain, Argentina, Colombia, Israel, Mexico, Portugal, Bulgaria, Germany, Malaysia, Romania, South Africa, Turkey, Korea, Republic of, Japan, Australia, Netherlands, Sweden, New Zealand and more
-
Alexion Pharmaceuticals, Inc.CompletedAtypical Hemolytic Uremic Syndrome (aHUS)Italy, United States, Korea, Republic of, Spain, Germany, Belgium, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingParoxysmal Nocturnal HemoglobinuriaUnited States, Germany, France, United Kingdom, Spain, Korea, Republic of, Turkey, Italy
-
Active Biotech ABCompletedProstate CancerFrance, Poland, Ukraine, United Kingdom, United States, China, Germany, Taiwan, Spain, Belgium, Colombia, Israel, Bulgaria, India, Panama, Romania, Netherlands, Greece, Sweden, Korea, Republic of, Australia, Canada, Chile, New Zealand, ... and more
-
Ascelia Pharma ABCompletedSevere Renal Impairment | Known or Suspected Focal Liver LesionsUnited States, Italy, Germany, Poland, Russian Federation, Sweden, Turkey, Argentina, Colombia, Mexico
-
River 3 Renal Corp.RecruitingFocal Segmental Glomerulosclerosis | Alport SyndromeUnited States, Belgium, United Kingdom, France, Germany, Netherlands
-
AbbottCompletedProstate CancerUnited States, Canada, France, Spain, Belgium, Australia, United Kingdom, Italy, Sweden, South Africa, Netherlands, Ireland, Germany, Austria, New Zealand, Greece, Poland, Switzerland
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell Carcinoma | Advanced Renal Cell CarcinomaSpain, Germany, United States, Austria, Czechia, United Kingdom, Argentina, Hungary, France, Canada, Chile
-
Otsuka Pharmaceutical Development & Commercialization...RecruitingAutosomal Recessive Polycystic Kidney Disease (ARPKD)United States, Belgium, Spain, Germany, United Kingdom, Poland
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerCanada, United States, Spain, Australia, Denmark, Korea, Republic of, Belgium, Singapore, Finland, Netherlands, France, Austria, Germany, Israel, United Kingdom, Italy, Japan, Lithuania, Poland, Russian Federation, Slovakia, Sweden
-
AIO-Studien-gGmbHPfizer; Crolll GmbhRecruitingRenal Cell Carcinoma, Metastatic | Renal Cell Cancer, RecurrentGermany
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyRecruitingEnd Stage Renal Disease | Primary Hyperoxaluria Type 2 | Primary Hyperoxaluria Type 1Germany, Spain, United States, United Kingdom, Italy, United Arab Emirates, Lebanon, Morocco, France, Romania
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States, France, Ukraine, United Kingdom, Belgium, Germany, Taiwan, Spain, Belarus, Israel, Portugal, Bulgaria, Romania, South Africa, Japan, Switzerland, Canada, Australia, Netherlands, Greece, Chile, New Zealand, Peru, Singapore, Russian Federation and more
-
Medtronic CardiovascularRecruitingAbdominal Aortic Aneurysm | Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder) | Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder)Japan, United States, Taiwan, France, Germany, Switzerland, Italy, Netherlands, Finland, Spain, United Kingdom
-
AstraZenecaCompletedNon-Metastatic Prostate CancerCzech Republic, Italy, South Africa, United Kingdom, Germany, Poland, Netherlands, Austria, Belgium, Hungary, Israel, Portugal, Mexico, Spain, Australia, Ireland
-
Eli Lilly and CompanyActive, not recruitingUrogenital Neoplasms | Prostatic Neoplasms | Neoplasm Metastasis | Enzyme Inhibitors | Antineoplastic Agents | Hormones | Physiological Effects of Drugs | Antineoplastic Agents, Hormonal | Androgens | Hormones, Hormone Substitutes, and Hormone Antagonists | Abiraterone Acetate | Steroid Synthesis Inhibitors | Cytochrome... and other conditionsChina, Canada, France, United States, Australia, Czechia, Hungary, Spain, Germany, Japan, Taiwan, Netherlands, Turkey, Mexico, Belgium, Korea, Republic of, Argentina, Romania, United Kingdom, Italy, Israel, Brazil, Poland, Greece
-
Merck Sharp & Dohme LLCModernaTX, Inc.RecruitingBladder CancerCanada, New Zealand, Germany, Australia, United States, Poland, Spain, Chile, Sweden, France, Italy
-
SOTIO a.s.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Spain, United Kingdom, Germany, Serbia, Portugal, Lithuania, Slovakia, Hungary, Netherlands, Croatia, France, Czechia, Poland, Austria, Belarus, Belgium, Bulgaria, Denmark, Italy, Latvia, Sweden
-
Bavarian NordicCompletedProstate Cancer MetastaticUnited States, Spain, Germany, Netherlands, Belgium, United Kingdom, Australia, Denmark, France, Canada, Israel, Russian Federation, Puerto Rico, Estonia, Poland, Iceland
-
AstraZenecaTerminatedProstate CancerSweden, United States, Brazil, Czech Republic, France, Italy, Peru, Russian Federation, Spain, Turkey, United Kingdom, Germany, China, Hungary, Latvia, Poland, Romania, Japan, Finland, Norway, Canada, South Africa, Argentina, Australia, Belgiu... and more
-
Genzyme, a Sanofi CompanyTerminatedAlport SyndromeAustralia, United States, China, France, Germany, Spain, United Kingdom
-
Hoffmann-La RocheCompletedBladder CancerUnited States, Spain, United Kingdom, Canada, France, Germany, Italy, Netherlands
-
AgennixCompletedProstate Cancer | Hormone Refractory Prostate CancerUnited States, United Kingdom, France, Italy, Israel, Germany, Hungary, Argentina, Russian Federation, Belgium, Croatia, Netherlands, Peru, Poland, Spain
-
Hoffmann-La RocheCompletedBladder CancerUnited States, Spain, United Kingdom, Canada, France, Germany, Italy, Netherlands
-
Astellas Pharma Global Development, Inc.Seagen Inc.RecruitingCarcinoma in Situ | Urinary Bladder Neoplasms | Non-muscle Invasive Bladder Cancer | Carcinoma Transitional Cell | NMIBCUnited States, Canada, France, Spain, United Kingdom, Germany
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, France, Spain, United Kingdom, Australia, Poland, Germany, Austria, Belgium, Netherlands, Italy, Chile, South Africa, Argentina